Rocket One Inc. Accounts Receivable, Allowance for Credit Loss
Rocket One Inc. (RKTO) had Accounts Receivable, Allowance for Credit Loss of $387.40 thousand as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2022-11-10
- 2022-09-30: Accounts Receivable, Allowance for Credit Loss $387.40K.
- 2022-06-30: Accounts Receivable, Allowance for Credit Loss $387.40K.
- 2021-12-31: Accounts Receivable, Allowance for Credit Loss $410.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss |
|---|---|
| 2022-09-30 | $387.40K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $387.40K 10-Q · filed 2022-08-12 |
| 2021-12-31 | $410.00K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |